Phase i study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma

European Journal of Cancer

Volumn 46, Issue 16, 2010, Pages 2943-2949

  Ruggiero, Antonio ^a   Rizzo, Daniela ^a   Attin, Giorgio ^a   Lazzareschi, Ilaria ^a   Mastrangelo, Stefano ^a   Maurizi, Palma ^a   Migliorati, Roberta ^b   Bertolini, Patrizia ^c   Pastore, Maria ^d   Colosimo, Cesare ^a   Riccardi, Riccardo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Pausilipon Hospital   (Italy)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

^d Casa Sollievo della Sofferenza   (Italy)

Author keywords

Children; Etoposide; Medulloblastoma; Oral chemotherapy; Phase I study; Temozolomide

Indexed keywords

ETOPOSIDE; TEMOZOLOMIDE;

ADOLESCENT; ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DRUG DOSE ESCALATION; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERTRANSLUCENT LUNG; MALE; MAXIMUM TOLERATED DOSE; MEDULLOBLASTOMA; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PNEUMOCYSTOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT CANCER; SCHOOL CHILD; STOMATITIS; THROMBOCYTOPENIA;

ADMINISTRATION, ORAL; ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CEREBELLAR NEOPLASMS; CHILD; DACARBAZINE; ETOPOSIDE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MAXIMUM TOLERATED DOSE; MEDULLOBLASTOMA; NEOPLASM RECURRENCE, LOCAL; TREATMENT OUTCOME;

EID: 78049256758     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.05.016     Document Type: Article

References (47)

1. C.C. Bailey, A. Gnekow, and S. Wellek Prospective randomised trial of chemotherapy given before radiotherapy in childhood MB. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II Med Pediatr Oncol 25 1995 166 178
2. R.J. Gilbertson Medulloblastoma: signalling a change in treatment Lancet Oncol 5 2004 209 218
3. A. Jones, and G.S. Innes Cerebrospinal irradiation for medulloblastoma Br J Radiol 30 1957 590 592
4. E. Paterson, and R.F. Farr Cerebellar medulloblastoma: treatment by irradiation of the whole central nervous system Acta Radiol 39 1953 323 336
5. C. Raffel Medulloblastoma: molecular genetics and animal models Neoplasia 6 2004 310 322
6. R.L. Heideman Overview of the treatment of infant central nervous system tumors: medulloblastoma as a model J Pediatr Hematol Oncol 23 2001 268 271
7. J.R. Geyer, R. Sposto, M. Jennings Children's Cancer Group Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group J Clin Oncol 23 2005 7621 7631
8. J. Grill, C. Sainte-Rose, A. Jouvet French Society of Paediatric Oncology Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children Lancet Oncol 6 2005 573 580
9. S. Rutkowski, U. Bode, and F. Deinlein Treatment of early childhood medulloblastoma by postoperative chemotherapy alone N Engl J Med 352 2005 978 986
10. J.L. Ater, J. van Eys, and S.Y. Woo MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children J Neurooncol 32 1997 243 252
11. A.W. Walter, R.K. Mulhern, and A. Gajjar Survival and neurodevelopmental outcome of young children with medulloblastoma at St. Jude Children's Research Hospital J Clin Oncol 17 1999 3720 3728
12. A. Gajjar, M. Chintagumpala, and D. Ashley Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St. Jude medulloblastoma-96): long-term results from a prospective, multicentre trial Lancet Oncol 7 2006 813 820
13. K.W. Sung, K.H. Yoo, and E.J. Cho High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor Pediatr Blood Cancer 48 2007 408 415
14. A. Perez-Martinez, A. Lassaletta, and M. Gonzalez-Vicent High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors J Neurooncol 71 2005 33 38
15. R.D. Kortmann, J. Kuhl, and B. Timmermann Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT'91 Int J Radiat Oncol Biol Phys 46 2000 269 279
16. R.E. Taylor, C.C. Bailey, and K. Robinson Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for non-metastatic medulloblastoma: the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study J Clin Oncol 21 2003 1581 1591
17. A.E. Evans, R.D. Jenkin, and R. Sposto The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone J Neurosurg 72 1990 572 582
18. H.S. Nicholson, C.S. Kretschmar, and M. Krailo Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group Cancer 110 2007 1542 1550
19. M.C. Chamberlain, and P.A. Kormanik Chronic oral VP-16 for recurrent medulloblastoma Pediatr Neurol 17 1997 230 234
20. D.M. Ashley, L. Meier, and T. Kerby Response of recurrent medulloblastoma to low-dose oral etoposide J Clin Oncol 14 1996 1922 1927
21. M.N. Needle, P.T. Molloy, and J.R. Geyer Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors Med Pediatr Oncol 29 1997 28 32
22. E.R. Lilley, M.C. Rosenberg, and G.B. Elion Synergistic interactions between cyclophosphamide or melphalan and VP-16 in a human rhabdomyosarcoma xenograft Cancer Res 50 1990 284 287
23. V.J. Patel, G.B. Elion, and P.J. Houghton Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft Clin Cancer Res 6 2000 4154 4157
24. D.N. Korones, M. Benita-Weiss, and T.E. Coyle Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma Cancer 97 2003 1963 1968
25. R. Stupp, P.Y. Dietrich, and S. Ostermann Kraljevic Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide J Clin Oncol 20 2002 1375 1382
26. Available from URL: .
27. J. Balter-Seri, C. Mor, A. Shuper, R. Zaizov, and I.J. Cohen Cure of recurrent medulloblastoma: the contribution of surgical resection at relapse Cancer 79 1997 1241 1247
28. C.F. Torres, S. Rebsamen, and J.H. Silber Surveillance scanning of children with medulloblastoma N Engl J Med 330 1994 892 895
29. M.G. Belza, S.S. Donaldson, G.K. Steinberg, R.S. Cox, and P.H. Cogen Medulloblastoma: freedom from relapse longer than 8 years - a therapeutic cure? J Neurosurg 75 1991 575 582
30. E. Bouffet, F. Doz, and M.C. Demaille Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse? Br J Cancer 77 1998 1321 1326
31. R. Riccardi, G. Cefalo, and A. Ruggiero High response rate to temozolomide in heavily pretreated children wit medulloblastoma AACR Proc 43 2002 748
32. A. Riccardi, G. Mazzarella, and G. Cefalo Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients Cancer Chemother Pharmacol 52 2003 459 464
33. K. Kiya, T. Uozumi, and H. Ogasawara Penetration of etoposide into human malignant brain tumors after intravenous and oral administration Cancer Chemother Pharmacol 29 1992 339 342
34. M.L. Slevin, P.I. Clark, and S.P. Joel A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer J Clin Oncol 7 1989 1333 1340
35. K.R. Hande, M.G. Krozely, F.A. Greco, J.D. Hainsworth, and D.H. Johnson Bioavailability of low-dose oral etoposide J Clin Oncol 11 1993 374 377
36. R.S. de Jong, N.H. Mulder, D. Dijksterhuis, and E.G. de Vries Review of current clinical experience with prolonged (oral) etoposide in cancer treatment Anticancer Res 15 1995 2319 2330
37. G. Toffoli, G. Corona, B. Basso, and M. Boiocchi Pharmacokinetic optimisation of treatment with oral etoposide Clin Pharmacokinet 43 2004 441 466
38. M.V. Relling, H.H. Mahmoud, and C.H. Pui Etoposide achieves potentially cytotoxic concentrations in CSF of children with acute lymphoblastic leukemia J Clin Oncol 14 1996 399 404
39. M.C. Chamberlain Recurrent brainstem gliomas treated with oral VP-16 J Neurooncol 15 1993 133 139
40. M.C. Chamberlain, and M.R. Grafe Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide J Clin Oncol 13 1995 2072 2076
41. M.C. Chamberlain Recurrent cerebellar gliomas: salvage therapy with oral etoposide J Child Neurol 12 1997 200 204
42. M.C. Chamberlain Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide Arch Neurol 54 1997 554 558
43. M. Prados Temozolomide in combination with other cytotoxic agents Semin Oncol 28 4 Suppl. 13 2001 24 33
44. D.N. Korones, A. Smith, N. Foreman, and E. Bouffet Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas Pediatr Blood Cancer 47 2006 37 41
45. M.C. Le Deley, G. Vassal, and A. Taïbi High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adults Pediatr Blood Cancer 45 2005 25 31
46. M.C. Le Deley, T. Leblanc, and A. Shamsaldin Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Franaise d'Oncologie Pédiatrique J Clin Oncol 21 2003 1074 1081
47. S.M. Davies Therapy-related leukemia associated with alkylating agents Med Pediatr Oncol 36 2001 536 540